Does Vitamin D Intake Decrease the Risk for Gestational Diabetes Mellitus?
BACKGROUND AND PURPOSE:
Previous studies on the association between vitamin D levels and gestational diabetes mellitus (GDM) have been inconsistent
Previous meta-analyses may have included studies that were not free of the Hawthorne effect
Hawthorne effect: Participants aware of their conditions and are therefore motivated to adopt healthier behaviors such as altering their vitamin D status
Also known as ‘observer effect’, such that study participants modify their behavior because they are aware of being observed
Zhang et al. (BJOG, 2017) sought to design a meta-analysis that would include as many relevant GDM-related indices as possible to better determine the association between Vitamin D intake and risk for GDM
Systematic review and meta-analysis
Literature review included
Observational studies on the relationship between vitamin D and GDM, free from Hawthorne effect
Randomized controlled trials (RCT) of vitamin D supplements during pregnancy for preventing or treating GDM
There was lack of agreement as to the definition of vitamin D deficiency
Some researchers used 50 nmol/l (20 ng/ml) and 75 nmol/l (30 ng/ml), while others used 25 nmol/l (10 ng/ml) and 50 nmol/l (20 ng/ml) to differentiate vitamin D deficiency, vitamin D insufficiency and vitamin D sufficiency
87 observational studies (55,859 participants) and 25 RCTs (2,445 participants) were included
Low blood vitamin D level during pregnancy was associated with a higher risk of GDM (odds ratio [OR] 1.850; 95% CI 1.471-2.328)
Blood vitamin D level was inversely correlated with HbA1c, FPG (fasting plasma glucose), HOMA-IR (homeostasis model of assessment for insulin resistance index) and FINS (fasting insulin)
Vitamin D supplementation during pregnancy impacted the blood levels of 25-hydroxyvitamin D, FINS FPG, GSH (glutathione), CRP (C-reactive protein), TC (total cholesterol), LDL, HDL and HOMA-IR
Results seen regarding the effect of vitamin D on, CRP, TC, LDL and HDL may have been related to publication biases
There was an association between low blood vitamin D levels and risk for GDM
Pregnant women with low blood vitamin D levels had 85% higher risk of GDM than those with regular vitamin D levels
Taking vitamin D supplements during pregnancy could help ameliorate GDM, although association strength is modest
While further research on effectiveness of vitamin D supplementation during pregnancy is still needed, it is likely that other lifestyle interventions to prevent GDM will still be necessary
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan